NMN raises NAD+ levels in humans with solid mechanistic rationale and early clinical data. Updated September 2025: FDA confirmed NMN lawful as a dietary supplement, reversing a 2022 exclusion.
MEMBERS ONLY
Continue Reading
This article is available to Vanguard members. Join to access all physician-curated content.